AllianceBernstein
VTAE

AllianceBernstein’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

AllianceBernstein’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-17,000
Closed -$356K – 3081
2016
Q3 		$356K Buy
17,000
+4,000
+31% +$46.1K ﹤0.01% 2650
2016
Q2 		$140K Buy
+13,000
New +$111K ﹤0.01% 2868

AllianceBernstein's VTAE Position: Q4 2016 in Review

AllianceBernstein sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 17,000 shares — an estimated $356K sold.

AllianceBernstein first reported a position in VTAE in Q2 2016 and held it in 2 quarters. The position peaked at $356K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • AllianceBernstein reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • AllianceBernstein sold 17,000 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $356K.
  • AllianceBernstein first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q2 2016 and held it in 2 quarters.
  • AllianceBernstein's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $356K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.